Home  |  Contact

Cellosaurus 1507.2 (CVCL_1Y71)

[Text version]
Cell line name 1507.2
Synonyms S1507-2
Accession CVCL_1Y71
Resource Identification Initiative To cite this cell line use: 1507.2 (RRID:CVCL_1Y71)
Disease Malignant peripheral nerve sheath tumor (NCIt: C3798)
Neurofibromatosis type 1 (NCIt: C3273)
Malignant peripheral nerve sheath tumor (ORDO: Orphanet_3148)
Neurofibromatosis type 1 (ORDO: Orphanet_636)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Category Cancer cell line
STR profile Source(s): PubMed=28556483

Markers:
AmelogeninX
CSF1PO11,12
D2S133818,23
D3S135817
D5S81811,12
D7S82012
D8S117914
D13S3179
D16S5399,10
D18S5112
D19S43313,15
D21S1128
FGA24
TH019.3
TPOX11,12
vWA15

Run an STR similarity search on this cell line
Publications

PubMed=21695156; DOI=10.1371/journal.pone.0021099
Spyra M., Kluwe L., Hagel C., Nguyen R., Panse J., Kurtz A., Mautner V.-F., Rabkin S.D., Demestre M.
Cancer stem cell-like cells derived from malignant peripheral nerve sheath tumors.
PLoS ONE 6:E21099-E21099(2011)

PubMed=23437333; DOI=10.1371/journal.pone.0057152
Reuss D.E., Mucha J., Hagenlocher C., Ehemann V., Kluwe L., Mautner V.-F., von Deimling A.
Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROS.
PLoS ONE 8:E57152-E57152(2013)

PubMed=28556483; DOI=10.1002/1878-0261.12086
Kolberg M., Bruun J., Murumagi A., Mpindi J.P., Bergsland C.H., Holand M., Eilertsen I.A., Danielsen S.A., Kallioniemi O.-P., Lothe R.A.
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
Mol. Oncol. 11:1156-1171(2017)

Cross-references
Encyclopedic resources Wikidata; Q54581966
Entry history
Entry creation22-Sep-2015
Last entry update21-Mar-2023
Version number5